Navigation Links
Sunrise Pharmaceutical, Inc. Sued for Violation of New Jersey Consumer Fraud Act

ESTERO, Fla., Sept. 17, 2013 /PRNewswire/ -- Vision Pharma, LLC has initiated a civil action against Sunrise Pharmaceutical, Inc. of Rahway, New Jersey in U.S. District Court for the District of New Jersey, Trenton Division. The nine-count lawsuit seeks to recover at least $3 million from Sunrise Pharmaceutical, plus statute-imposed, mandatory treble damages and attorney fees pursuant to NJ Stat. Ann. § 56:8-19, stemming from Sunrise Pharmaceutical's defective manufacture of certain drug products deemed adulterated and unsalable by the U.S. Food & Drug Administration (FDA) as well as Sunrise Pharmaceutical's willful sale of said adulterated drugs to Vision Pharma without notice of the FDA's investigations and determinations.  The case is styled Vision Pharma, LLC v. Sunrise Pharmaceutical Inc., C.A. No. 2:13-cv-04692-CCC-JAD and is now pending before the Hon. Claire C. Cecchi.

A full list of the nine (9) causes of action asserted by Vision Pharma upon which it seeks relief from the U.S. District Court is as follows:

Count 1:  Violation of New Jersey Consumer Fraud Act
Count 2:  Breach of Contract
Count 3:  Willful Breach of Implied Warranty of Merchantability
Count 4:  Breach of Implied Warranty of Fitness for a Particular Purpose
Count 5:  Breach of Covenant of Good Faith and Fair Dealing
Count 6:  Unjust Enrichment
Count 7:  Negligence
Count 8:  Deceptive Trade Practices
Count 9:  Fraud & Deceit

"It is very unfortunate that we had to file suit against Sunrise Pharmaceutical after numerous attempts to resolve these issues amicably; however, the severe damage they caused our company left this as the only option.  We are certainly prepared for a trial by jury and taking this case to the end for a well-deserved victory," said Sander S. Busman, Founder, President & CEO, Vision Pharma.  Vision Pharma is being represented by lead counsel Cameron S. Reuber, Esq. and a team of attorneys at Leason Ellis LLP.

About Vision Pharma
Vision Pharma specializes in niche, generic pharmaceuticals with various delivery options and dosage forms. The company provides quality products at competitive prices while improving the lives of those who take their medicines. The organization's customer service acts promptly to requests while continuously improving to fulfill each customer and patient need. Maintaining additional inventory ensures Vision's ability to provide increased service levels. The pipeline of generic pharmaceuticals planned to market continues to be a strong focus internally and with other pharmaceutical organizations, domestically and internationally. Valuable relationships that are built show true dedication to each partnering company. You can count on Vision Pharma to consider the patient's safety as a top priority when developing and manufacturing their items. To learn more, please visit

Media Relations Contact:
Sander S. Busman                                                                  
Vision Pharma
Founder, President & CEO


SOURCE Vision Pharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
2. New Air Products Microsite Features Advanced Liquid Nitrogen Solutions for the Chemical, Pharmaceutical, and Life Science Industries
3. Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
4. Earnings Forecast Stock Alerts: American International Group, Teva Pharmaceutical, CSX, Exxon Mobil, Lowes, and Seagate
5. CorePharma Addresses Violations in FDA Warning Letter
6. Federal Government Targets Small, Mid-sized Practices for Probes of Patient Privacy Violations
7. Cardiac Science signs contract to provide Powerheart AEDs to the state of New Jersey
8. Big Pharma to Come Together at ChemOutsourcing 2013 in Long Branch, New Jersey, Sept 16-19
9. ChemOutsourcing Announces 100 CMO and CRO Exhibitors for September 2013 Show in Long Branch, New Jersey
10. ChemOutsourcing Announces 30 Pharma Company Presenters for September 2013 Outsourcing Show in New Jersey
11. NJBIZ Honors New Jerseys General Counsels
Post Your Comments:
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
Breaking Medicine News(10 mins):